Concepedia

Craig M. Goodwin

CM

Statistics

Publications

15

Citations

1.6K

H-Index

14

Active since

2011

Affiliations

University of North Carolina at Chapel Hill(Current)

George Mason University

Vanderbilt University

Dana-Farber Cancer Institute

Broad Institute

Craig M. Goodwin is an author at University of North Carolina at Chapel Hill specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2011–2024

15

Publications

15

Drugging an undruggable pocket on KRAS

Dirk Kessler, Michael Gmachl, Andreas Mantoulidis et al. · Proceedings of the National Academy of Sciences · 2019 · 434 citations · Full text

, , +15

Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer

G. Aaron Hobbs, Nicole M. Baker, Anne M. Miermont et al. · Cancer Discovery · 2019 · 226 citations · Full text

, , +12

Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer

Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp et al. · Cancer Research · 2022 · 160 citations · Full text

, , +17

Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods

Nicholas F. Pelz, Zhiguo Bian, Bin Zhao et al. · Journal of Medicinal Chemistry · 2016 · 147 citations · Full text

, , +17

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers

Jeffrey A. Klomp, Jeffrey A. Klomp, Jennifer E. Klomp et al. · Science · 2024 · 108 citations · Full text

, , +17

1–5 of 15